Back to Journals » OncoTargets and Therapy » Volume 12

Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis [Corrigendum]

Authors Xue J, Astère M, Zhong M, Lin H, Shen J, Zhu Y

Received 1 April 2019

Accepted for publication 1 April 2019

Published 11 April 2019 Volume 2019:12 Pages 2749—2750

DOI https://doi.org/10.2147/OTT.S210748


Xue J, Astère M, Zhong M, Lin H, Shen J, Zhu Y. Onco Targets Ther. 2018;11:6119–6128.
The article type for this paper was listed as a “Review” and it needs to be changed to “Original Research”.
 
 Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]